A man files a Roundup and lymphoma lawsuit on behalf of his deceased spouse against the weed killer’s manufacturer Monsanto, alleging that she developed cancer as a direct and proximate result of Roundup use and exposure.
Plaintiff Edmond C. files the Roundup and lymphoma lawsuit on behalf of Joyce C. The lawsuit was filed in Missouri federal court on March 15, 2018.
According to the Roundup and lymphoma lawsuit, Edmond, the surviving spouse, is a resident of Tennessee, as was his spouse Joyce at the time of her death.
Edmond states that for years, Joyce would spray Roundup on a regular basis. She also followed all “safety and precautionary warnings” for its use. However, Edmond claims that following sustained exposure to Roundup and the product’s active glyphosate ingredient, the lawsuit alleges, Joyce developed Non-Hodgkin’s Lymphoma.
“The development of Decedent Plaintiff’s Non-Hodgkin’s Lymphoma was proximately and actually caused by exposure to Defendant’s Roundup products,” the lawsuit states.
Due to the exposure and cancer diagnosis, the couple allegedly incurred significant economic and non-economic damages.
Edmond’s Roundup and lymphoma lawsuit was filed on multiple counts including negligence, design defect, failure to warn, breach of implied warranties, breach of express warranty, wrongful death, survival action. He demands a trial by jury.
Roundup and Lymphoma Facts
Monsanto faces a multitude of allegations against them purporting that Roundup’s glyphosate ingredient is carcinogenic and causes the development of a variety of cancers, including non-Hodgkin’s lymphoma.
The company faces accusations that they knew the chemical’s risks for causing cancer but falsely represented the safety of Roundup.
According to the lawsuit, Monsanto is a multinational biotechnology corporation that is the leading glyphosate producer in the world. They discovered glyphosate and its herbicidal properties in the 1970s and immediately began to sell glyphosate-based products like Roundup.
It was in 1996 that Monsanto faced a lawsuit by the New York Attorney General (NYAG) that was “based on its false and misleading advertising of Roundup products.”
Representations made by Monsanto of the Roundup product was that it was “safer than table salt” and “practically non-toxic” to birds, fish, and mammals, the lawsuit states.
Glyphosate Dangers
The Environmental Protection Agency (EPA) first classified glyphosate as a Category C oncogene on March 4, 1985. Category C oncogenes are “possible human carcinogens with limited evidence of carcinogenicity.”
The International Agency for Research on Cancer (IARC) also issued a formal monograph on July 29, 2015, classifying glyphosate as a Group 2A carcinogen–a classification meaning that it is possibly carcinogenic to humans.
Even so, some reports claim that “glyphosate formulations” or the formula of Roundup as a whole is even “more dangerous and toxic than glyphosate alone.”
According to the lawsuit, France has long noted and realized the dangers that Roundup provided to its consumers. It also realized that Monsanto failed to tell the truth about Roundup’s safety. As a result, in 2009, France’s highest court affirmed judgement that Monsanto falsely advertised its marketing claims.
The Roundup and Lymphoma Lawsuit is Case No. 4:18-cv-00413-DDN, in the U.S. District Court for the Eastern District of Missouri.
If you or a loved one developed cancer after using Roundup as a farm worker or home gardener, you may have a legal claim. Legal migrant farm workers may also seek help. Learn more by filling out the form on this page for a FREE case evaluation.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Roundup Cancer Class Action Lawsuit Investigation
For the most up-to-date information on this case, click here.